A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
A Prospective Observational Study to the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
1 other identifier
observational
300
1 country
1
Brief Summary
The trial was designed as a single-center non-interventional prospective observational study to explore the role and impact of wearable smart devices in perioperative NSCLC patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2023
CompletedFirst Submitted
Initial submission to the registry
October 27, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedJune 28, 2024
June 1, 2024
1.4 years
October 27, 2023
June 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative length of hospital stay
Postoperative Length of Stay (LOS) refers to the duration of a patient's hospitalization following surgery, typically measured from the completion of the surgical procedure to the time of patient discharge.
From time of surgery to time of discharge from the hospital (assessed up to 30 days)
Secondary Outcomes (1)
Operative time
From time of the start of surgery to the end of surgery
Study Arms (1)
NSCLC patients wearing wearable smart devices
NSCLC patients wearing wearable smart devices while utilizing PROs for regular follow-up
Interventions
Patients wearing wearable smart devices to monitor physiological data while regularly utilizing PROs to report subjective assessments of their own health status.
Eligibility Criteria
Continuously enroll all patients with non-small cell lung cancer, histopathologically confirmed
You may qualify if:
- Participants must provide voluntary consent to participate in this research and possess the capacity to sign an informed consent form.
- Participants must be aged over 18 years.
- Participants must have undergone pulmonary resection surgery with a postoperative pathological confirmation of primary lung cancer.
You may not qualify if:
- Patient refusal to participate in this research.
- Inability to wear wearable smart monitoring devices due to various reasons.
- History of secondary lung cancer surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jianxing He, M.D
The First Affiliated Hospital of Guangzhou Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 27, 2023
First Posted
November 7, 2023
Study Start
March 9, 2023
Primary Completion
July 31, 2024
Study Completion
March 31, 2026
Last Updated
June 28, 2024
Record last verified: 2024-06